Fierce Healthcare
FEBRUARY 1, 2022
Kindbody hits unicorn status with Vios Fertility Institute acquisition, new leadership additions. rtorrence. Tue, 02/01/2022 - 17:13.
Outsourcing Pharma
FEBRUARY 1, 2022
On World Cancer Day, the Union for International Cancer Control is launching a three-year campaign with the goal to improve cancer care around the globe.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Healthcare
FEBRUARY 1, 2022
Unvaccinated 23 times more likely than boosted to be hospitalized during omicron wave. dmuoio. Tue, 02/01/2022 - 16:13.
pharmaphorum
FEBRUARY 1, 2022
The new BA.2 subvariant of Omicron is around 50% more transmissible than the original BA.1 strain, and there is somewhat conflicting evidence on its ability to evade the protection from vaccines, according to new studies. BA.2 is now the dominant strain of the COVID-19 virus in Denmark, and scientists from the country’s Statens Serum Institute (SSI) have compared the two subvariants in more than 8,500 households including almost 18,000 people.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
FEBRUARY 1, 2022
Healthcare data breaches hit all-time high in 2021, impacting 45M people. hlandi. Tue, 02/01/2022 - 16:25.
pharmaphorum
FEBRUARY 1, 2022
Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. But what does it take to implement these innovations? Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinical trial design that have historically led to trial failure?
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Outsourcing Pharma
FEBRUARY 1, 2022
During OSPâs exclusive February 23 webinar Rare and Orphan Diseases, leading expertswill lend their unique experience and expertise to the important topic.
Fierce Healthcare
FEBRUARY 1, 2022
Beaumont Health, Spectrum Health complete 22-hospital merger to form Michigan's largest health system. dmuoio. Tue, 02/01/2022 - 09:54.
pharmaphorum
FEBRUARY 1, 2022
Real-World Evidence 2022: Rare Diseases and Innovative Therapies (RWE 2022) will convene the full spectrum of stakeholders working in RWE in rare diseases and innovative therapies, including pharma and biotech, medical device companies, health technology assessors (HTAs), regulators, payers, academics, patient advocacy groups and service providers – to discuss how we accelerate RWE and regulatory approval in a post-COVID and post-Brexit world.
Fierce Healthcare
FEBRUARY 1, 2022
Healthcare Dealmakers—IBM sells off Watson Health assets; Centene closes Magellan Health acquisition. dmuoio. Tue, 02/01/2022 - 12:31.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
McCreadie Group
FEBRUARY 1, 2022
February 2022 | Vincent Puglia Clinical trial technology is typically a constellation of systems and devices that exists in a continuum with the subject at its center and cocentric rings extending out to sites, partners, providers, CROs, and sponsors. A good clinical trial system (sometimes called “eClinical system”) will enhance efficiency and speed during the.
Fierce Healthcare
FEBRUARY 1, 2022
Value-based care physician group in Florida lands $500M in its first capital investment. agliadkovskaya. Tue, 02/01/2022 - 11:44.
pharmaphorum
FEBRUARY 1, 2022
Not only did the COVID-19 pandemic bring lockdown rules and increased safety protocols, it also led to delays, reconfigurations, limited patient access, and other restrictions for life science research and development. However, one benefit is that it accelerated innovations underway to solve long-standing clinical process issues. “The pandemic turbo-charged trial decentralisation,” says Caroline Redeker, senior vice president, corporate development at Advanced Clinical.
Fierce Healthcare
FEBRUARY 1, 2022
PointClickCare Technologies picks up Audacious Inquiry to expand care coordination network. hlandi. Tue, 02/01/2022 - 07:17.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
FEBRUARY 1, 2022
After a phase 3 trial win, Madrigal Pharmaceuticals reckons it could succeed where so many other companies have failed, and finally bring a drug to market to treat the liver disease non-alcoholic steatohepatitis (NASH). Its lead candidate resmetirom met its primary and secondary objectives in the trial, which involved patients with non-alcoholic fatty liver disease (NAFLD) including some with presumed NASH , with significant improvements in measures of liver and cardiovascular health over a 52-w
Fierce Healthcare
FEBRUARY 1, 2022
League gets $95M for 'digital front door' consumer-centric healthcare platform. rtorrence. Tue, 02/01/2022 - 13:20.
pharmaphorum
FEBRUARY 1, 2022
Over the past two years, life sciences media has been flooded with headlines about the rise of digital health systems. The sudden arrival of COVID-19 lit a fire under an industry that had previously lagged behind others in its adoption of technology. With limited physical access to labs and patients, the influx of updated technology was a welcome change.
Fierce Healthcare
FEBRUARY 1, 2022
Physician practices make revenue gains in 2021 but face mounting expenses, labor shortages. hlandi. Tue, 02/01/2022 - 13:00.
Impact Pharmaceutical Services
FEBRUARY 1, 2022
Boston, MA (February 1, 2022) – Syner-G BioPharma Group (“Syner-G” or the “Company”), a leading provider of Chemistry, Manufacturing, and Controls (“CMC”) technical, regulatory, and compliance consulting services to pharmaceutical and biotechnology clients, today announced the acquisition of Impact Pharmaceutical Services (“IMPACT”).
Fierce Healthcare
FEBRUARY 1, 2022
Sen. Casey: UnitedHealth has reprocessed more than 1.6M claims for COVID-19 vaccines. pminemyer. Tue, 02/01/2022 - 13:47.
Impact Pharmaceutical Services
FEBRUARY 1, 2022
Boston, MA (February 1, 2022) – Syner-G BioPharma Group (“Syner-G” or the “Company”), a leading provider of Chemistry, Manufacturing, and Controls (“CMC”) technical, regulatory, and compliance consulting services to pharmaceutical and biotechnology clients, today announced the acquisition of Impact Pharmaceutical Services (“IMPACT”).
Fierce Healthcare
FEBRUARY 1, 2022
Florida Blue parent GuideWell closes acquisition of Triple-S Management. pminemyer. Tue, 02/01/2022 - 11:32.
Pharma Times
FEBRUARY 1, 2022
Market authorisation for twice yearly schizophrenia treatment which offers patients much-needed medication continuity
pharmaphorum
FEBRUARY 1, 2022
Telehealth came to the fore in in 2020 and 2021 as healthcare systems struggled to deal with the consequences of the pandemic, but the coming year could see big changes to the sector after a period of breakneck growth. A new report from Boston Consulting Group’s Digital Ventures team predicts that with the category becoming increasingly crowded there will be consolidation as the early movers try to stay ahead of upstart competition – as already seen with 2020’s $18.5 billion merger b
Pharma Times
FEBRUARY 1, 2022
Ayvakyt receives a positive opinion from the CHMP for the treatment of adults with advanced systemic mastocytosis
pharmaphorum
FEBRUARY 1, 2022
A study has shown that a ‘smart’ stethoscope developed by US digital health company Eko can be used to screen people for heart failure in a few second during a standard physical examination. The device tested in the independent study combines a stethoscope used to listen to heart sounds with a single-lead electrocardiogram (ECG). It uses an algorithm to detects low left ventricular ejection fraction (LVEF) – reduced outflow of blood from the heart to the aorta – which is a common cha
Fierce Healthcare
FEBRUARY 1, 2022
Republican governors in West Virginia and Virginia ask CMS to get out of vaccine mandate. rking. Tue, 02/01/2022 - 12:13.
pharmaphorum
FEBRUARY 1, 2022
The MHRA has kicked off an eight-week consultation on proposals for changes to laws governing the conduct of clinical trials following the UK’s departure from the EU. The proposals stem from the passage of the Medicines and Medical Devices Act 2021 a year ago, shortly after the post-Brexit transition period ended, which has given the UK government sweeping powers to amend existing regulations.
Expert insights. Personalized for you.
129 
Let's personalize your content